These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: [Clinical efficacy of sairei-to in prevention of recurrence of urethral stenosis: report of two cases].
    Author: Tozawa K, Akita H, Yamamoto H, Nakahira Y, Kawai T, Kohri K.
    Journal: Hinyokika Kiyo; 1998 Jan; 44(1):49-51. PubMed ID: 9503210.
    Abstract:
    Sairei-to has been reported to inhibit granulation and fibroblast proliferation. We administered Sairei-to (9.0 g/day) to two 77-year-old men with repeated urethral stenosis after transurethral resection of prostate (TUR-P) and examined its clinical effects. Urethral stricture did not recur in these patients for 7 to 8 months. There were no side effects in these patients. Sairei-to is suggested to be useful to prevent recurrence of urethral stricture after a transurethral procedure.
    [Abstract] [Full Text] [Related] [New Search]